Nick’s recent representations include:

• AstraZeneca and its officers as alleged controlling stockholder of Viela Bio in a Delaware Court of Chancery stockholder challenge to Horizon Therapeutics’ acquisition of Viela Bio.
• Moderna and its officers and directors in a securities class action and related derivative actions alleging false statements in connection with Moderna’s RSV vaccine. 
• Palantir and its officers and directors in a securities class action and related derivative actions challenging statements made in connection with Palantir’s direct listing about growth, efficiencies, revenue targets, and operations.
• Tyson Foods and its officers and directors in a securities class action and related derivative actions alleging failure to disclose purportedly insufficient COVID-19 safety protocols at Tyson facilities.
• J.P. Morgan, Barclays, Goldman Sachs, Citigroup and seven additional financial institutions in a securities class action concerning underwriting of a healthcare company’s IPO.
• BuzzFeed and its officers and directors in a Delaware Court of Chancery action seeking an anti-arbitration injunction and enforcement of BuzzFeed’s forum clause. 
• CarLotz and its officers and directors in a securities class action and related derivative actions alleging failure to disclose information about CarLotz’s business model, partnerships, inventory, and unit economics.
• Acelyrin and its officers and directors in a securities class action challenging statements made in connection with Acelyrin’s IPO about its clinical trials and the potential of its lead drug candidate, Izokibep.
• Li-Cycle in securities class action challenging statements concerning Li-Cycle’s lithium-ion battery recycling methods and financial reporting. 
• Society for Corporate Governance as amicus curiae before the United States Supreme Court in a securities class action concerning corporate disclosures.